These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3556742)

  • 41. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology.
    Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A
    Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 43. Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.
    Chevalier FD; Le Clec'h W; Eng N; Rugel AR; Assis RR; Oliveira G; Holloway SP; Cao X; Hart PJ; LoVerde PT; Anderson TJ
    Int J Parasitol; 2016 Jun; 46(7):417-24. PubMed ID: 27073078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppression and parasitic diseases: experimental Schistosomiasis mansoni.
    Gargione C; Vellosa SA; Hoshino-Shimizu S; Okumura M; Chiodelle SG
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(3):122-8. PubMed ID: 10436644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 46. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Properties and drug sensitivity of adenosine triphosphatases from Schistosoma mansoni.
    Nechay BR; Hillman GR; Dotson MJ
    J Parasitol; 1980 Aug; 66(4):596-600. PubMed ID: 6448282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are Ca2+ channels targets of praziquantel action?
    Greenberg RM
    Int J Parasitol; 2005 Jan; 35(1):1-9. PubMed ID: 15619510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoprophylactic activity of known schistosomicidal agents.
    Pellegrino J; Pereira LH; Mello RT
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):43-6. PubMed ID: 897475
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutagenic evaluation of antischistosomal drugs and their derivatives in Neurospora crassa.
    Ong T; de Serres FJ
    J Toxicol Environ Health; 1975 Nov; 1(2):271-9. PubMed ID: 128637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
    Jewsbury JM
    Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of a new schistosomicidal agent 2-[(methylpropyl)amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate.
    Penido ML; Coelho PM; Nelson DL
    Mem Inst Oswaldo Cruz; 1999; 94(6):811-3. PubMed ID: 10585660
    [No Abstract]   [Full Text] [Related]  

  • 53. Genetic activity spectra of some antischistosomal compounds, with particular emphasis on thioxanthenones and benzothiopyranoindazoles.
    Hartman PE; Hulbert PB
    J Toxicol Environ Health; 1975 Nov; 1(2):243-70. PubMed ID: 1107580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex and drugs in Schistosoma mansoni.
    Mattoccia LP; Lelli A; Cioli D
    J Parasitol; 1982 Apr; 68(2):347-9. PubMed ID: 6176705
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunostimulation as adjuvant for the chemotherapy of experimental schistosomiasis.
    Silva LM; Andrade ZA
    Rev Inst Med Trop Sao Paulo; 1997; 39(1):11-4. PubMed ID: 9394530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cultivation of schistosomes for chemotherapeutic studies.
    Frandsen F
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():118-22. PubMed ID: 7344405
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug resistance in schistosomiasis: a review.
    Bruce JI; Dias LC; Liang YS; Coles GC
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():143-50. PubMed ID: 3151088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of the clinical pharmacology of hycanthone.
    Dennis EW; Kobus W
    Egypt J Bilharz; 1974; 1(1):35-53. PubMed ID: 4619885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.